Home > Adults > COVID-19 >

Acute Assessment

Checked: 23-04-2021 by Vicky Ryan Next Review: 23-04-2022

BNSSG - Remote assessment guidance

Please see the BNSSG Primary care assessment and management of Covid-19, and of all people (Covid and non-Covid) requiring admission (last updated 20.04.21).

The guideline can be used when making management decisions on patients with suspected or confirmed COVID-19. You also have the additional option of referring into the COVID Oximetry@Home service run by Sirona for patients who meet the criteria.

The guidelines advise use of the Charlson Comorbidity Index which may support clinical decision making when discussing appropriateness of admission with our patients.

There is also information in this guidance on:

COVID-19 in the community
Cardiopulmonary Resuscitation
Children and COVID-19
Assessing severity of COVID-19 on the telephone
Frailty and comorbidities
When to consider antibiotics and antibiotic choice
Safety netting
Face to face assessment
Video consultations
Safeguarding, domestic violence and vulnerable people
Adults with COVID-19 and asthma
Adults with COVID-19 and COPD
End of life, death verification and certification

Please also see NICE COVID-19 rapid guideline: managing COVID-19 (NG191) which make reference to assessments using the Clinical Frailty Score (CFS).These guidelines make it clear that ‘the CFS should not be used in younger people, people with stable long-term disabilities, for example cerebral palsy, learning disability or autism.

Acute Assessment and Monitoring in Primary Care

See the COVID Oximetry@Home page.

Resources

Other resources:

NICE guidelines - COVID-19 rapid guideline: managing COVID-19 (NG191)

COVID-19: a remote assessment in primary care (25.3.20) - BMJ 10 minute consultation guide.

RECAP (Remote COVID-19 Assessment in Primary Care) project is a collaboration between the University of Oxford and Imperial College London with the aim of developing a tool to assist primary care providers in the identification of those COVID- 19 patients at risk of becoming severe, in order to facilitate the rapid escalation of their treatment and increase the chances of better outcomes.

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.